The average duration of follow-up was 5.6 ± 3.8 SD years (range 3 months-12 years) in 19 patients, as five asymptomatic patients with CPT-I deficiency were only seen once. The gene discussed is CPT1A; the disease is hyperinsulinemic hypoglycemia, familial, 4.